Literature DB >> 411934

Inhibitors of Bacillus subtilis DNA polymerase III. 6-(arylalkylamino)uracils and 6-anilinouracils.

N C Brown, J Gambino, G E Wright.   

Abstract

6-(Benzylamino)uracils and substituted 6-anilinouracils have been found to be potent inhibitors of Bacillus subtilis DNA polymerase III by a mechanism identical with that of 6-(phenylhydrazino)uracils. Higher phenylalkylamino homologues are progressively weaker inhibitors of the enzyme. Examination of the effects of substituents on the activity of 6-(benzylamino)uracils against wild-type and mutant enzymes and preliminary results for 6-anilinouracils have permitted further dissection of the mechanism of inhibition. The experimental results indicate that (1) the polymerase inhibitor binding site is compact, accommodating only small alterations in the distance between the uracil and phenyl rings, (2) the phenyl ring, which provides the major contribution to inhibitor-enzyme binding, adopts a specific active conformation, and (3) an enzyme site which interacts with substituents in the phenyl ring forms a part of the active site of DNA polymerase III.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 411934     DOI: 10.1021/jm00219a015

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

1.  Bacillus subtilis dnaF: a mutation of the gene specifying the structure of DNA polymerase III.

Authors:  M J Vrooman; M H Barnes; N C Brown
Journal:  Mol Gen Genet       Date:  1978-09-08

2.  Butylanilinouracil: a selective inhibitor of HeLa cell DNA synthesis and HeLa cell DNA polymerase alpha.

Authors:  G E Wright; E F Baril; N C Brown
Journal:  Nucleic Acids Res       Date:  1980-01-11       Impact factor: 16.971

3.  Inhibitors of DNA polymerase III as novel antimicrobial agents against gram-positive eubacteria.

Authors:  P M Tarantino; C Zhi; G E Wright; N C Brown
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

4.  Low frequencies of resistance among Staphylococcus and Enterococcus species to the bactericidal DNA polymerase inhibitor N(3)-hydroxybutyl 6-(3'-ethyl-4'-methylanilino) uracil.

Authors:  Michelle M Butler; Donna J Skow; Ryan O Stephenson; Patrick T Lyden; William A LaMarr; Kimberly A Foster
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

5.  Development of novel inhibitor probes of DNA polymerase III based on dGTP analogs of the HPUra type: base, nucleoside and nucleotide derivatives of N2-(3,4-dichlorobenzyl)guanine.

Authors:  M M Butler; L W Dudycz; N N Khan; G E Wright; N C Brown
Journal:  Nucleic Acids Res       Date:  1990-12-25       Impact factor: 16.971

6.  In vitro antimicrobial activities of novel anilinouracils which selectively inhibit DNA polymerase III of gram-positive bacteria.

Authors:  J S Daly; T J Giehl; N C Brown; C Zhi; G E Wright; R T Ellison
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

7.  Comparative Studies to Uncover Mechanisms of Action of N-(1,3,4-Oxadiazol-2-yl)benzamide Containing Antibacterial Agents.

Authors:  George A Naclerio; Kenneth I Onyedibe; Caroline W Karanja; Uma K Aryal; Herman O Sintim
Journal:  ACS Infect Dis       Date:  2022-03-17       Impact factor: 5.578

8.  Design and characterization of N2-arylaminopurines which selectively inhibit replicative DNA synthesis and replication-specific DNA polymerases: guanine derivatives active on mammalian DNA polymerase alpha and bacterial DNA polymerase III.

Authors:  G E Wright; E F Baril; V M Brown; N C Brown
Journal:  Nucleic Acids Res       Date:  1982-07-24       Impact factor: 16.971

9.  Glymes as Versatile Solvents for Chemical Reactions and Processes: from the Laboratory to Industry.

Authors:  Shaokun Tang; Hua Zhao
Journal:  RSC Adv       Date:  2014       Impact factor: 3.361

10.  DNA polymerases of low-GC gram-positive eubacteria: identification of the replication-specific enzyme encoded by dnaE.

Authors:  Marjorie H Barnes; Shelley D Miller; Neal C Brown
Journal:  J Bacteriol       Date:  2002-07       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.